INOVIV
We develop bespoke biomarker tests to identify patients and demonstrate treatment efficacy for novel therapeutics. Our tests support pharmaceutical companies in running successful clinical trials and in maximising access to marketed therapies.
INOVIV
Social Links:
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Medical Medical Device
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.inoviv.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)20 3290 1587
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Sectigo SSL Sectigo Domain SSL
Similar Organizations
Canostix
Canostix is developing a multi-cancer screening blood test that combines photonics and machine learning.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Xip
Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
Current Employees Featured
Founder
Official Site Inspections
http://www.inoviv.com
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inoviv"
Home - Inoviv
Inoviv provides pre-validated, fully calibrated custom multiplexed LC-MS biomarker panels for an array of diseases. Are you ready to decipher your novel drug, protein by protein? Pick your …See details»
About Us - Inoviv
Inoviv's mission is to generate novel molecular insights that transform drug development and healthcare globally. ... and sold the largest fully funded entrepreneuring accelerator in the UK. …See details»
Inoviv - Crunchbase Company Profile & Funding
Inoviv has 4 investors including Foresight Group and Hoxton Ventures. When was the last funding round for Inoviv? Inoviv closed its last funding round on Jan 30, 2024 from a Venture - Series …See details»
Inoviv - LinkedIn
Inoviv is thrilled to welcome Jennifer D'Angelo to the team as our new Senior Business Development Manager for the West Coast US! Jennifer brings extensive experience in revenue growth, strategic ...See details»
Careers - Inoviv
Inoviv’s mission is to generate novel molecular insights that transform drug development and healthcare globally. Considering that 60% of therapeutics don’t work and over 92% of clinical trials fail, the losses to the patient and drug …See details»
Inoviv - Funding, Financials, Valuation & Investors - Crunchbase
Jan 30, 2024 Inoviv has raised 3 rounds. Their latest funding was raised on Jan 30, 2024 from a Venture - Series Unknown round. Inoviv is funded by 4 investors. Foresight Group and Hoxton …See details»
Inoviv Locations - Contract Research Map
136 High Holborn Hogarth House London, WC1V 6PX United Kingdom Inoviv, a leading biotechnology company, uses advanced LC-MS-based quantitative proteomics to enhance the …See details»
Inoviv Company Profile - Office Locations, Competitors, Revenue
Inoviv Summary. Company Summary. Overview. Inoviv is a company that develops biomarker tests to match patients with the right drugs. Its solutions are targeted protein, lipid and …See details»
Inoviv 2025 Company Profile: Valuation, Funding & Investors
Inoviv General Information Description. Developer of a proteomics platform intended to provide molecular insights on drug response. The company's platform uses an accurate, fully …See details»
Inoviv - 2025 Company Profile - Tracxn
6 days ago Inoviv. has raised a total funding of $3.44M over 3 rounds. Its first funding round was on Nov 19, 2018. What are the most recent funding rounds of Inoviv? Its latest funding round …See details»
Inoviv - Products, Competitors, Financials, Employees, …
Inoviv primarily serves the pharmaceutical industry, aiding in patient stratification, treatment monitoring, and providing mechanistic insights for therapies. It was founded in 2017 and is …See details»
Inoviv - VentureRadar
Inoviv matches patients with the right drugs. We develop blood tests for major diseases to work out which patients will respond to drugs. Our unique technology, based on targeted …See details»
Solutions - Inoviv
Proteomics Solutions from discovery to pre-validated and custom multiplexed biomarker panels for proteins, PTMs, lipids, metabolites, and moreSee details»
Inoviv - Updates, News, Events, Signals & Triggers - Crunchbase
Inoviv may be growing as it has secured an investment aimed at expanding its quantitative proteomics product offerings, which are integral to its role in accelerating drug development …See details»
Inoviv - FS Ventures
Inoviv’s solution is designed to enrol the right patients and demonstrate efficacy of new drugs, increasing clinical trial success rates by over 3X. Its biomarker tests can optimise patient …See details»
Inoviv - LinkedIn
Inoviv is thrilled to welcome Jennifer D'Angelo to the team as our new Senior Business Development Manager for the West Coast US! Jennifer brings extensive experience in …See details»
Techweek | Inoviv - Developing blood tests to match patients with …
Jan 28, 2020 Inoviv works with pharmaceutical companies to develop biomarker tests supporting investigational and marketed therapeutics. The company identifies and stratifies patients to …See details»
Inoviv - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Inoviv . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 3. ... Inoviv has …See details»
Inoviv secures investment to expand quantitative proteomics …
LONDON, January 30, 2024–(BUSINESS WIRE) –– Biomarker pioneer Inoviv has secured significant funding from venture capital firm Hoxton Ventures and leading investment manager …See details»
Inoviv Overview - Unbiased Identification of Patient Signatures
Feb 28, 2023 Inoviv’s Neurodegenerative Biomarker Panels for Targeted Proteomics combine 50+ fully calibrated biomarkers to cover multiple aspects of disease pathology. Explore our …See details»